Literature DB >> 22465174

Alzheimer's disease: pathogenesis and prevention.

Heiko Braak1, Kelly Del Tredici.   

Abstract

Tau lesions (pretangles, neuropil threads, neurofibrillary tangles) in select neuronal types are essential to the pathogenesis of Alzheimer's disease. Pretangle formation marks the beginning of the pathological process and is of particular interest because it is temporally closer to the prevailing conditions that induce the pathological process underlying Alzheimer's disease in contrast to late-stage disease. However, not all pretangles convert into neurofibrillary tangles. We propose that the development of tau lesions in Alzheimer's disease is traceable to differences between early- versus late-maturing oligodendrocytes and to the exceptionally protracted myelination of late-developing portions of the human brain. Conclusions drawn from these considerations should encourage development of new preventative and disease-modifying strategies.
Copyright © 2012 The Alzheimer's Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22465174     DOI: 10.1016/j.jalz.2012.01.011

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  23 in total

Review 1.  Resistance, vulnerability and resilience: A review of the cognitive cerebellum in aging and neurodegenerative diseases.

Authors:  Katharine J Liang; Erik S Carlson
Journal:  Neurobiol Learn Mem       Date:  2019-01-07       Impact factor: 2.877

Review 2.  [Pathogenesis and prevention of Alzheimer's disease: when and in what way does the pathological process begin?].

Authors:  H Braak; S Feldengut; K Del Tredici
Journal:  Nervenarzt       Date:  2013-04       Impact factor: 1.214

3.  Removing inter-subject technical variability in magnetic resonance imaging studies.

Authors:  Jean-Philippe Fortin; Elizabeth M Sweeney; John Muschelli; Ciprian M Crainiceanu; Russell T Shinohara
Journal:  Neuroimage       Date:  2016-02-23       Impact factor: 6.556

4.  Soluble forms of tau are toxic in Alzheimer's disease.

Authors:  Katherine J Kopeikina; Bradley T Hyman; Tara L Spires-Jones
Journal:  Transl Neurosci       Date:  2012-09       Impact factor: 1.757

5.  Differences between early and late onset Alzheimer's disease.

Authors:  Peter K Panegyres; Huei-Yang Chen
Journal:  Am J Neurodegener Dis       Date:  2013-11-29

6.  Molecular drivers and cortical spread of lateral entorhinal cortex dysfunction in preclinical Alzheimer's disease.

Authors:  Usman A Khan; Li Liu; Frank A Provenzano; Diego E Berman; Caterina P Profaci; Richard Sloan; Richard Mayeux; Karen E Duff; Scott A Small
Journal:  Nat Neurosci       Date:  2013-12-22       Impact factor: 24.884

Review 7.  Origins of Alzheimer's disease: reconciling cerebrospinal fluid biomarker and neuropathology data regarding the temporal sequence of amyloid-beta and tau involvement.

Authors:  Erik S Musiek; David M Holtzman
Journal:  Curr Opin Neurol       Date:  2012-12       Impact factor: 5.710

8.  Lentiviral delivery of the human wild-type tau protein mediates a slow and progressive neurodegenerative tau pathology in the rat brain.

Authors:  Raphaëlle Caillierez; Séverine Bégard; Katia Lécolle; Vincent Deramecourt; Nadège Zommer; Simon Dujardin; Anne Loyens; Noëlle Dufour; Gwennaëlle Aurégan; Joris Winderickx; Philippe Hantraye; Nicole Déglon; Luc Buée; Morvane Colin
Journal:  Mol Ther       Date:  2013-04-23       Impact factor: 11.454

9.  Cognitive Outcomes During COVID-19 Confinement Among Older People and Their Caregivers Using Technologies for Dementia: Protocol for an Observational Cohort Study.

Authors:  Jessica Marian Goodman-Casanova; Elena Dura-Perez; Gloria Guerrero-Pertiñez; Pilar Barnestein-Fonseca; Jose Guzman-Parra; Amanda Vega-Nuñez; Esperanza Varela-Moreno; Antonio Cuesta-Vargas; Fermin Mayoral-Cleries
Journal:  JMIR Res Protoc       Date:  2021-05-18

10.  Barriers in health and social care access and navigation for elder orphans: a scoping review protocol.

Authors:  Lucy Kervin; Kelly Teo; Ryan Churchill; Indira Riadi; Theodore D Cosco
Journal:  BMJ Open       Date:  2021-05-31       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.